Tag Archives: pNETs
FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer
The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs). pNETs is a rare, slow-growing form of pancreatic cancer. In theUnited States, there are fewer than 1000 new pNET cases … Continue reading
Posted in Cancer, Pancreatic Cancer
Tagged advanced renal cell carcinoma, Afinitor, Everolimus, FDA, mTOR, Nexavar, pancreatic neuroendocrine tumors, pNETs, RADIAN-3, sorafenib, subependymal giant cell astrocytoma, sunitinib, Sutent, tuberous sclerosis
Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer